Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Datasets
Search by expertise, name or affiliation
Prot #C34002: An Open-Label, Phase 1b/2 Study Investigating Recommended Phase 2 Dose, Safety, Tolerability, and Preliminary Efficacy of TAK-659 in Adult Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)
Frankfurt, Olga
(PD/PI)
Kaplan, Jason B
(Other)
Medicine, Hematology Oncology Division
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
2/25/15
→
2/28/21
Funding
Quintiles, Inc.
(Prot #C34002)
Millennium Pharmaceuticals, Inc
(Prot #C34002)
View all
View less